Opexa Publication Of Tovaxin(R) Clinical Data In Journal Of Clinical Immunology
Opexa Therapeutics, Inc. (NASDAQ: OPXA), a company developing a novel T-cell therapy for multiple sclerosis (MS) and a stem cell therapy for diabetes, today announced that data from its Phase I/II dose escalation study has been recently published in the May 2009 edition of the prestigious Journal of Clinical Immunology. Encouraging data from this clinical study paved the way for the larger Phase IIb TERMS trial that was completed in late 2008.
Monday, April 27, 2009
Ohioans Urged To Vaccinate Against Pertussis
Pertussis – also known as whooping cough – sickens hundreds of Ohioans every year and the Ohio Department of Health (ODH) wants to help you protect yourself and your loved ones from this vaccine-preventable disease.
Pertussis – also known as whooping cough – sickens hundreds of Ohioans every year and the Ohio Department of Health (ODH) wants to help you protect yourself and your loved ones from this vaccine-preventable disease.
“This common and potentially serious illness can be prevented with vaccine,” said ODH Director Alvin D. Jackson, M.D. “Please see your doctor to see if pertussis vaccine is recommended for you and your loved ones.”
Source:
Ohio Department of Health Sunday, April 26, 2009
An Independent Study Reports On The Utility Of ImmuKnow(R), The Cylex(TM) Immune Cell Function Assay, For Monitoring Heart Transplant Recipients
An Independent Study Reports On The Utility Of ImmuKnow(R), The Cylex(TM) Immune Cell Function Assay, For Monitoring Heart Transplant Recipients
Since it was cleared as an in vitro assessment of cell-mediated immunity in immunosuppressed patient populations, numerous clinical investigations have contributed to defining the role of the Cylex ImmuKnow assay among recipients of solid organ transplants.
Since it was cleared as an in vitro assessment of cell-mediated immunity in immunosuppressed patient populations, numerous clinical investigations have contributed to defining the role of the Cylex ImmuKnow assay among recipients of solid organ transplants.
Subscribe to:
Posts (Atom)
